Asena GÖKÇAY CANPOLAT, Demet ÇORAPÇIOĞLU, Mustafa ŞAHİN, Özgür DEMİR, Koray CEYHAN, Rıfat EMRAL, Murat Faik ERDOĞAN, Sevim GÜLLÜ, Serpil SAK

Calcitonin levels in washout samples vs. cytology in the detection of malignant lymph node metastasis in recurrent medullary thyroid cancer

Background/aim: Calcitonin level in fine-needle aspirate washout fluid (Ct-FNA) was extensively studied for thyroid nodules and lymph nodes (LN). However, the data was scarce for neck recurrences/metastases of medullary thyroid cancer (MTC). Thus, the diagnostic accuracy of Ct-FNA and cytology in the detection of neck LN metastases of recurrent MTC cases were assessed. Materials and methods: The database of MTC patients between 2010 and 2021 was retrospectively reviewed. A total of 32 patients with recurrent MTC and suspicious LN who underwent FNA and Ct measurement from washout samples were included in this study. Preoperative serum Ct (sCt), Ct-FNA, Ct-FNA/sCt ratio, cytology data were recorded for all participants. Results: Median sCt of 32 patients and Ct-FNA washout fluid levels of operated suspicious 44 LNs were 723 (54–9000) pg/mL and 1800 (151–9500) pg/mL, respectively. The diagnostic accuracy of Ct-FNA washout fluid was greater than cytology (95.4% vs. 86%, respectively). Using a cut-off level of >638.5 pg/mL, the Ct-FNA predicted the diagnosis of LN metastasis of recurrent MTC with a sensitivity of 80% and specificity of 94.9%. Furthermore, using a cut-off level of >1.16, the Ct-FNA/sCt ratio well predicted the diagnosis of LN metastasis of recurrent MTC with a sensitivity of 92.3% and specificity of 100%. Conclusion: As Ct-FNA has greater diagnostic accuracy in our study, it would be complementary to cytology results to localize metastatic LNs in recurrent MTC. Furthermore, for the first time, we demonstrated that the Ct-FNA/sCt ratio was a better predictor of metastatic LNs in recurrent MTC than a particular cut-off for Ct-FNA alone.Key words: Recurrent medullary thyroid cancer, fine needle aspiration cytology, calcitonin, washout sample

PDF

___

1. Boi F, Maurelli I, Pinna G, Atzeni F, Piga M et al. Calcitonin measurement in wash-out fluid from fine needle aspiration of neck masses in patients with primary and metastatic medullary thyroid carcinoma. Journal of Clinical Endocrinology and Metabolism 2007; 92(6):2115-2118. doi: 10.1210/jc.2007-0326
2. Torresan F, Cavedon E, Mian C, Iacobone M. Long-Term Outcome After Surgery for Medullary Thyroid Carcinoma: A Single-Center Experience. World Journal Surgery 2018;42(2):367-375. doi: 10.1007/s00268-017-4321-z
3. Rowland KJ, Jin LX, Moley JF. Biochemical cure after reoperations for medullary thyroid carcinoma: a meta-analysis. Annals of Surgical Oncology 2015;22(1):96-102. doi: 10.1245/ s10434-014-4102-y
4. Jin LX, Moley JF. Surgery for lymph node metastases of medullary thyroid carcinoma: A review. Cancer 2016;122(3):358-366. doi: 10.1002/cncr.29761
5. Stamatakos M, Paraskeva P, Stefanaki C, Katsaronis P, Lazaris A et al. Medullary thyroid carcinoma: The third most common thyroid cancer reviewed. Oncology Letters 2011;2(1):49-53. doi: 10.3892/ol.2010.223
6. Randle RW, Balentine CJ, Leverson GE, Havlena JA, Sippel RS et al. Trends in the presentation, treatment, and survival of patients with medullary thyroid cancer over the past 30 years. Surgery 2017;161(1):137-146. doi: 10.1016/j.surg.2016.04.053
7. de Crea C, Raffaelli M, Maccora D, Carrozza C, Canu G et al. Calcitonin measurement in fine-needle aspirate washouts vs. cytologic examination for diagnosis of primary or metastatic medullary thyroid carcinoma. Acta Otorhinolaryngolica Italica 2014; 34(6):399-405
8. Kihara M, Hirokawa M, Kudo T, Hayashi T, Yamamoto M et al. Calcitonin measurement in fine-needle aspirate washout fluid by electrochemiluminescence immunoassay for thyroid tumors. Thyroid Research 2018;11:15. doi: 10.1186/s13044- 018-0059-4
9. Trimboli P, Treglia G, Guidobaldi L, Romanelli F, Nigri G et al. Detection rate of FNA cytology in medullary thyroid carcinoma: a meta-analysis. Clinical Endocrinology (Oxf) 2015;82(2):280-285. doi: 10.1111/cen.12563
10. Trimboli P, Guidobaldi L, Bongiovanni M, Crescenzi A, Alevizaki M et al. Use of fine-needle aspirate calcitonin to detect medullary thyroid carcinoma: A systematic review. Diagnostic Cytopathology 2016;44(1):45-51. doi: 10.1002/ dc.23375
11. Wells SA, Jr., Asa SL, Dralle H, Elisei R, Evans DB et al. Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma. Thyroid 2015;25(6):567-610. doi: 10.1089/thy.2014.0335
12. Marques B, Cunha N, Martins RG, Elvas AR, Couto J et al. Lymph Node Metastases of Medullary Thyroid Cancer: Role of Calcitonin in the Washout Fluid of Fine-Needle Aspiration. International Journal of Endocrinology 2020;2020:9267972. doi: 10.1155/2020/9267972
13. Kebebew E, Kikuchi S, Duh QY, Clark OH. Long-term results of reoperation and localizing studies in patients with persistent or recurrent medullary thyroid cancer. Archieves of Surgery 2000;135(8):895-901. doi: 10.1001/archsurg.135.8.895
14. Haugen BR, Alexander EK, Bible KC, Doherty GM, Mandel SJ et al. 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid 2016;26(1):1-133. doi: 10.1089/thy.2015.0020
15. Baldini E, Sorrenti S, Di Gioia C, De Vito C, Antonelli A et al. Cervical lymph node metastases from thyroid cancer: does thyroglobulin and calcitonin measurement in fine needle aspirates improve the diagnostic value of cytology? MC Clinical Pathology 2013;13:7. doi: 10.1186/1472-6890-13-7
16. Elisei R, Bottici V, Luchetti F, Di Coscio G, Romei C et al. Impact of routine measurement of serum calcitonin on the diagnosis and outcome of medullary thyroid cancer: experience in 10,864 patients with nodular thyroid disorders. The Journal of Clinical Endocrinology and Metabolism 2004;89(1):163-168. doi: 10.1210/jc.2003-030550
17. Massaro F, Dolcino M, Degrandi R, Ferone D, Mussap M et al. Calcitonin assay in wash-out fluid after fine-needle aspiration biopsy in patients with a thyroid nodule and border-line value of the hormone. Journal of Endocrinological Investigation 2009;32(4):308-312. doi: 10.1007/BF03345717
18. Kudo T, Miyauchi A, Ito Y, Takamura Y, Amino N et al. Diagnosis of medullary thyroid carcinoma by calcitonin measurement in fine-needle aspiration biopsy specimens. Thyroid 2007;17(7):635-638. doi: 10.1089/thy.2006.0338
19. Suzuki A, Hirokawa M, Takada N, Higuchi M, Ito A et al. Fineneedle aspiration cytology for medullary thyroid carcinoma: a single institutional experience in Japan. Endocrine Journal 2017;64(11):1099-1104. doi: 10.1507/endocrj.EJ17-0238
20. Trimboli P, Cremonini N, Ceriani L, Saggiorato E, Guidobaldi L et al. Calcitonin measurement in aspiration needle washout fluids has higher sensitivity than cytology in detecting medullary thyroid cancer: a retrospective multicentre study. Clinical Endocrinology (Oxf) 2014;80(1):135-140. doi: 10.1111/cen.12234
21. Stack BC, Jr., Ferris RL, Goldenberg D, Haymart M, Shaha A et al. American Thyroid Association Surgical Affairs C: American Thyroid Association consensus review and statement regarding the anatomy, terminology, and rationale for lateral neck dissection in differentiated thyroid cancer. Thyroid 2012;22(5):501-508. doi: 10.1089/thy.2011.0312
22. Chang TC, Wu SL, Hsiao YL. Medullary thyroid carcinoma: pitfalls in diagnosis by fine needle aspiration cytology and relationship of cytomorphology to RET proto-oncogene mutations. Acta Cytologica 2005;49(5):477-482. doi: 10.1159/000326191
23. Forrest CH, Frost FA, de Boer WB, Spagnolo DV, Whitaker D et al. Medullary carcinoma of the thyroid: accuracy of diagnosis of fine-needle aspiration cytology. Cancer 1998; 84(5):295- 302. doi: 10.1002/(sici)1097-0142(19981025)84:5<295::aidcncr5>3.0.co;2-j
24. Diazzi C, Madeo B, Taliani E, Zirilli L, Romano S et al. The diagnostic value of calcitonin measurement in wash-out fluid from fine-needle aspiration of thyroid nodules in the diagnosis of medullary thyroid cancer. Endocrine Practice 2013;19(5):769-779. doi: 10.4158/EP12420.OR
25. Trimboli P, D’Aurizio F, Tozzoli R, Giovanella L. Measurement of thyroglobulin, calcitonin, and PTH in FNA washout fluids. Clinical Chemistry and Laboratory Medicine 2017;55(7):914- 925. doi: 10.1515/cclm-2016-0543
26. Giovanella L, Ceriani L, Bongiovanni M. Calcitonin measurement on fine needle washouts: preanalytical issues and normal reference values. Diagnostic Cytopathology 2013;41(3):226-329. doi: 10.1002/dc.22804
27. Gokcay Canpolat A, Sahin M, Ediboglu E, Erdogan MF, Gullu S et al. Diagnostic accuracy of parathyroid hormone levels in washout samples of suspicious parathyroid adenomas: A singlecentre retrospective cohort study. Clinical Endocrinology (Oxf) 2018;89(4):489-495. doi: 10.1111/cen.13812